WIA
TELO icon

World Investment Advisors’s Telomir Pharmaceuticals TELO Stock Holding History

World Investment Advisors’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.1K Buy
37,037
+1,600
+5% +$2.04K ﹤0.01% 1552
2025
Q4 		$47.1K Buy
+35,437
New +$51.1K ﹤0.01% 1453

Other funds holding TELO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

World Investment Advisors's TELO Position: Q1 2026 in Review

World Investment Advisors increased its Telomir Pharmaceuticals (TELO) stake by 4.5% in Q1 2026, buying an estimated $2.04K and bringing the position to 37,037 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

World Investment Advisors first reported a position in TELO in Q4 2025 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold TELO as of Q1 2026.

  • World Investment Advisors held 37,037 shares of Telomir Pharmaceuticals worth $48.1K as of Q1 2026.
  • World Investment Advisors bought 1,600 Telomir Pharmaceuticals shares in Q1 2026, an estimated $2.04K.
  • Telomir Pharmaceuticals made up ﹤0.01% of World Investment Advisors's portfolio in Q1 2026, its #1552 holding.
  • World Investment Advisors first reported a position in Telomir Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 27 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q1 2026.

Based on World Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.